Accessibility Menu
 
Adagene logo

Adagene

(NASDAQ) ADAG

Current Price$3.78
Market Cap$177.69M
Since IPO (2021)-87%
5 Year-79%
1 Year+126%
1 Month+19%

Adagene Financials at a Glance

Market Cap

$177.69M

Revenue (TTM)

$103.20K

Net Income (TTM)

$55.44M

EPS (TTM)

$-0.64

P/E Ratio

-5.85

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$3.78

Volume

3,383

Open

$4.00

Previous Close

$3.78

Daily Range

$3.64 - $4.13

52-Week Range

$1.30 - $4.58

ADAG News

No articles available.

ADAG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adagene

Industry

Biotechnology

Employees

138

CEO

Peizhi Luo, PhD

Headquarters

Suzhou, 215123, CN

ADAG Financials

Key Financial Metrics (TTM)

Gross Margin

-11%

Operating Margin

-412%

Net Income Margin

-372%

Return on Equity

-63%

Return on Capital

-1%

Return on Assets

-58%

Earnings Yield

-17.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$177.69M

Shares Outstanding

47.13M

Volume

3.38K

Short Interest

0.00%

Avg. Volume

185.04K

Financials (TTM)

Gross Profit

$823.04K

Operating Income

$35.95M

EBITDA

$31.66M

Operating Cash Flow

$29.70M

Capital Expenditure

$33.58K

Free Cash Flow

$29.73M

Cash & ST Invst.

$85.19M

Total Debt

$18.49M

Adagene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$300.33K

-1607.5%

Gross Margin

N/A

N/A

Market Cap

$177.69M

N/A

Market Cap/Employee

$1.29M

N/A

Employees

138

N/A

Net Income

$13.51M

-82.1%

EBITDA

$12.89M

-41.8%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$55.98M

-36.1%

Accounts Receivable

$2.45K

-98.9%

Inventory

$0.00

N/A

Long Term Debt

$88.71K

-99.4%

Short Term Debt

$6.76M

-21.3%

Return on Assets

-57.77%

N/A

Return on Invested Capital

-1.12%

N/A

Free Cash Flow

$11.16M

N/A

Operating Cash Flow

$11.16M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FBIOFortress Biotech, Inc.
$2.76-4.17%
GANXGain Therapeutics, Inc.
$1.83-3.17%
XBITXBiotech Inc.
$2.27-1.73%
ACETAdicet Bio, Inc.
$6.47-3.86%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About ADAG

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.